Savvy Update, 1/20/25: Glucagon RXs UP … BUT, Gut Bacterium Helps Cut Sugar Cravings, FDA Bans Red Dye, Red Meat Increases Dementia Risk, Empathy-Focused Calls Boost Self-Care, FTC 2nd Report Slams PMBs, BG Levels Pasta/Pizza Spike More in America, California Insulin Delayed, Ozempic Picked for Medicare Price Reduction, Adam Brown on Self-Talk & Juggling, Clinical Trial T1D & CKD, Omnipod Next-Gen?

Savvy Update, 1/20/25: Glucagon RXs UP … BUT, Gut Bacterium Helps Cut Sugar Cravings, FDA Bans Red Dye, Red Meat Increases Dementia Risk, Empathy-Focused Calls Boost Self-Care, FTC 2nd Report Slams PMBs, BG Levels Pasta/Pizza Spike More in America, California Insulin Delayed, Ozempic Picked for Medicare Price Reduction, Adam Brown on Self-Talk & Juggling, Clinical Trial T1D & CKD, Omnipod Next-Gen?

Jan 20, 2025 | Advocacy, Diabetes Business, Featured, Foods, Research News, Technology Updates, Videos

LOTS to READ in this week’s issue of The Savvy Diabetic:  Glucagon Prescriptions are UP … BUT Fall Short of Meeting Demand Special Gut Bacterium Could Help Cut Sugar Cravings FDA bans controversial red dye Processed Red Meat Increases Dementia Risk...
Savvy Updates, 1/13/25: Sana Islet Cell Transplants w/out Immunosuppression, Beta Bionics Files IPO, Glooko/Hedia Launches D Management Tech, CeQur $$ for Simplicity Patch Pump, Glucose Monitoring with Sweat, Medical Debt Removed from Credit, Coffee Best in AM

Savvy Updates, 1/13/25: Sana Islet Cell Transplants w/out Immunosuppression, Beta Bionics Files IPO, Glooko/Hedia Launches D Management Tech, CeQur $$ for Simplicity Patch Pump, Glucose Monitoring with Sweat, Medical Debt Removed from Credit, Coffee Best in AM

Jan 13, 2025 | Advocacy, Featured, Foods, Research News, Technology Updates

Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression released by Sana.com, 7 January 2025. Sana Biotechnology, Inc., a company focused on changing the possible for patients through...
Savvy Updates, 12/23/24: Modular Medical Pump/Nudge BG, Dexcom & Generative AI, Lantidra for Brittle T1D, Endocrinologist Shortage, Global T1D Market at US$15.95 billion in 2024 with Compound Annual Growth of 6.2% by 2031

Savvy Updates, 12/23/24: Modular Medical Pump/Nudge BG, Dexcom & Generative AI, Lantidra for Brittle T1D, Endocrinologist Shortage, Global T1D Market at US$15.95 billion in 2024 with Compound Annual Growth of 6.2% by 2031

Dec 23, 2024 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

Modular Medical Announces Licensing and Partnership Agreement With Nudge BG was announced by AccessWire.com, 19 December 2024. Modular Medical, Inc., an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs...
Savvy Updates, 12/16/24: ADA DiabetesStandards of Care 2025, Cleerly CCTA, Eversense 365 Day CGM Video, Insulin Resistance & Aortic Stenosis, Medtronic CGM Data on Displays, Effort to Force Insurers, PBMs to Sell Pharmacy Businesses, Medicare Open Enrollment Stress

Savvy Updates, 12/16/24: ADA DiabetesStandards of Care 2025, Cleerly CCTA, Eversense 365 Day CGM Video, Insulin Resistance & Aortic Stenosis, Medtronic CGM Data on Displays, Effort to Force Insurers, PBMs to Sell Pharmacy Businesses, Medicare Open Enrollment Stress

Dec 16, 2024 | Featured, Research News, Technology Updates

In this week’s issue of The Savvy Diabetic:  ADA DiabetesStandards of Care 2025 Cleerly Coronary Computed Tomography Angiography (CCTA) Video: Implantable 365-Day CGM Procedure Biomarkers of Insulin Resistance & Aortic Stenosis Medtronic CGM Data on...
Savvy Updates, 12/9/24: Insulet Awarded $452m in EOFlow Patent Fight, Dark Chocolate Good for T2D, T1D DKA Risk Differs with SGLT2 Inhibitor Doses, Mary Tyler Moore Vision Initiative to Combat Vision Loss in Diabetes

Savvy Updates, 12/9/24: Insulet Awarded $452m in EOFlow Patent Fight, Dark Chocolate Good for T2D, T1D DKA Risk Differs with SGLT2 Inhibitor Doses, Mary Tyler Moore Vision Initiative to Combat Vision Loss in Diabetes

Dec 9, 2024 | Advocacy, Diabetes Business, Featured, Research News, Technology Updates

Insulet awarded $452M in EOFlow patent fight by Elise Reuter for MedTechDive.com, 5 December 2024. Insulet sued EOFlow and three former executives who joined the South Korea-based patch-pump maker, claiming the company “launched a plan to brazenly copy Insulet’s...
Skip to content